GIP + GLP-1 co-agonism
Balanced dual-receptor activity.
FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from peer-reviewed literature for educational reference.
Metabolic Peptide
GLP-2
- Tirzepatide
- LY3298176
- GIP/GLP-1 Co-Agonist
A 39-residue dual GIP/GLP-1 receptor agonist used as a research compound in metabolic and incretin-signaling studies.
- Free shipment protection
- Free shipping on $250+
- Damage protection
- 256-bit SSL checkout
C20 fatty-diacid
Albumin-binding tail for extended half-life characterization.
99%+ identity purity
HPLC + MS verified per batch. CoA included.
What Is GLP-2?
GLP-2 (tirzepatide-class) is a synthetic 39-residue dual agonist engineered for balanced activity at the GIP and GLP-1 receptors with an attached C20 fatty-diacid for albumin binding. Characterized in incretin and metabolic-signaling research literature.
Technical specifications
Type
Synthetic 39-residue dual agonist
Molecular weight
4813.5 g/mol
Appearance
White lyophilized powder
Identity purity
≥ 99% (HPLC + MS)
Peer-reviewed research
- N Engl J MedTirzepatide Once Weekly for the Treatment of Obesity
- N Engl J MedTirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Frequently researched together
IMPORTANT RESEARCH NOTICE
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.